Document Type
Article
Publication Date
9-23-2024
Keywords
Asian tiger mosquito, methoprene, Bacillus thuringiensis var, israelensis, fluralaner
Abstract
The objective of this study was to compare the efficacy of a proprietary yeast microencapsulated (YME) fluralaner formulation (U.S. Provisional Patent: P2871US00) to the commercial off-the-shelf (COTS) products, Altosid SR-20 (Central Life Sciences, Dallas, TX; AI: (S)-Methoprene 20%) and VectoBac 12AS (Valent BioSciences, Libertyville, IL; AI: Bacillus thuringiensis israelensis 11.61%) for controlling mosquito larvae.
Citation
Cierra Briggs, Blythe E Lawson, Emily G McDermott, Comparison of yeast microencapsulated fluralaner to commercially available mosquito larval control products, 2023, Arthropod Management Tests, Volume 49, Issue 1, 2024, tsae105, https://doi.org/10.1093/amt/tsae105
Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
